Contact: Matt Godson
Tel: 212 352 3220 x 264
Email: m.godson@americanconference.com
New York
October 24, 2005
ACI: Drug and Medical Device Litigation Conference to Address Top Critical Issues Threatening Pharmaceutical and Device Companies
The American Conference Institute, organizers of the 10 th Annual Drug and Medical Device Litigation conference taking place December 12-14, 2005 in New York , today announced the results of their exclusively commissioned research into the most pressing issues currently faced by the pharmaceutical and medical device industries.
Program Director Seth Eichenholtz remarked, “This research is the culmination of many weeks of contacts and detailed discussion with 124 senior individuals at law firms, pharmaceutical manufacturers, and medical device companies at the ‘sharp end’ of drug and medical device litigation.”
Eichenholtz continued, “Many organizations are becoming increasingly concerned not just at the recent wave of lawsuits and enforcement actions, but also the longer term ramifications on the industry and the public. Our research has pinpointed the areas of primary focus.”
Four key areas of concern were raised:
- Turmoil at the FDA
Uncertainty over FDA enforcement initiatives, responses to FDA personnel shakeups, and likely ramifications of the Drug Safety Oversight Board on the industry and the public
- COX-2 litigation
Questions over possible outcomes and accurate analysis of the first Vioxx verdict, product recall tactics, coordination of multidistrict litigation strategies, and navigating the Class Action Fairness Act
- Trial Techniques
Unique obstacles to jury communication and the challenges posed by the need to enhance expression of scientific data, effective examination of expert witnesses, and de-bunking of junk science
- Crisis management
Developing public relations best practices for various crises, and understanding the costs of a failure to address PR concerns
The Drug and Medical Device Litigation Conference in December, sponsored by the American Conference Institute, will focus on providing solutions to leading companies and their outside counsel facing these challenges.
Full information on the forum can be found at www.drugandmed.com |